Fudan University: all 1,308 studies
Page 3 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.
- Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With ImmunotherapyNot yet recruitingNCT07164690Phase 2
- The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver TumorsRecruitingNCT07159048Not applicable
- Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT07156604Phase 2
- Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric RetentionNot yet recruitingNCT07156591
- Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal CancerRecruitingNCT07154316Phase 2
- De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority TrialNot yet recruitingNCT07153757Phase 3
- T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain MetastasisRecruitingNCT07152782Phase 2
- Iparomlimab and Tuvonralimab Combined With GC in Advanced ICCNot yet recruitingNCT07152769Phase 2
- Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility ScoresNot yet recruitingNCT07152756
- Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)RecruitingNCT07150949Phase 2
- T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain MetastasisRecruitingNCT07150208Phase 2
- Development and Validation of an Artificial Intelligence-assisted System for Bowel Cleanliness Assessment Based on Withdrawal Distance WeightingNot yet recruitingNCT07150130
- Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune MicroenvironmentRecruitingNCT07147101
- Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma.Not yet recruitingNCT07147088Phase 2
- Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain MetastasesRecruitingNCT07134153Phase 1/2
- Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 StudyRecruitingNCT07132463Phase 3
- Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein MarkerNot yet recruitingNCT07120451Phase 2
- Zhongshan Ketogenic Diet Study 1RecruitingNCT07117903Not applicable
- Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon MutationsRecruitingNCT07117890Phase 2
- Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian CancerNot yet recruitingNCT07117877Phase 2
- A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's DiseaseRecruitingNCT07117851Phase 2
- An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard TherapyRecruitingNCT07117630Phase 2
- Perioperative Immunotherapy for Resectable Limited-Stage SCLCRecruitingNCT07109401Phase 2
- Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung CancerNot yet recruitingNCT07107035
- HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)RecruitingNCT07105748Phase 2
- A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell CarcinomaRecruitingNCT07105592Phase 1/2
- TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune MicroenvironmentRecruitingNCT07100405
- Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and BevacizumabRecruitingNCT07100392Phase 2
- Transparent Cap-Assisted Colonoscopy Combined With Computer-Aided Detection in Improving the Detection Rate of Colorectal AdenomasNot yet recruitingNCT07097350Not applicable
- Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled StudyNot yet recruitingNCT07095699Not applicable
- Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic CholangiocarcinomaRecruitingNCT07070700Phase 2
- Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PETRecruitingNCT07070648
- Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After RadiotherapyRecruitingNCT07067268Phase 2
- An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal CancerNot yet recruitingNCT07061210Phase 2
- Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and BevacizumabRecruitingNCT07047586Phase 2
- Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast CancerNot yet recruitingNCT07041437Phase 2
- Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung CancerNot yet recruitingNCT07034365
- Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal CancerNot yet recruitingNCT07025850Phase 1/2
- Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC PatientsNot yet recruitingNCT07021261Phase 3
- CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)RecruitingNCT07019363Phase 3
- RGL-305+ Lymphoma + Exploratory Clinical StudyRecruitingNCT07006012Not applicable
- Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast CancerNot yet recruitingNCT07005557Phase 3
- Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRCRecruitingNCT07003022Phase 2
- Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous TransplantationRecruitingNCT07001540Phase 2
- Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer PatientsNot yet recruitingNCT06999252Phase 2
- UEMR Versus HSP in the Treatment of Pedunculated Colorectal Polyps Less Than 10mm in SizeNot yet recruitingNCT06996522Not applicable
- Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 InhibitorNot yet recruitingNCT06996093Phase 3
- A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)RecruitingNCT06992882Phase 3
- The Effect of Cap-assisted Water Exchange Colonoscopy on Straight Passage of the Colonoscope Through the Sigmoid Colon, Without Loop FormationNot yet recruitingNCT06992856Not applicable
- TACE Plus Ivonescimab for Unresectable Non-Metastatic HCCNot yet recruitingNCT06990620Phase 1
- GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）RecruitingNCT06988592
- Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast CancerNot yet recruitingNCT06977542Phase 2
- Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian CancerNot yet recruitingNCT06973421Phase 2
- Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid CancerRecruitingNCT06970353Phase 2
- A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCLRecruitingNCT06966154Phase 1/2
- A Real World Study of Sacituzumab GovitecanRecruitingNCT06966141
- Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization StageNot yet recruitingNCT06965556Not applicable
- Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II TrialRecruitingNCT06965231Phase 2
- CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCCRecruitingNCT06964568Phase 3
- Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal CarcinomaNot yet recruitingNCT06957938Phase 3
- Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal CancerNot yet recruitingNCT06956976Not applicable
- Prospective Gastric Cancer Screening With Fecal Multi-target DNA AnalysisRecruitingNCT06943807
- Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled TrialNot yet recruitingNCT06943794Not applicable
- Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism DetectionRecruitingNCT06943781
- Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes TestNot yet recruitingNCT06943768
- Breast Cancer PET/CT Imaging With 68Ga-pAKTiEnrolling by invitationNCT06943313
- Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)RecruitingNCT06943235Phase 2
- Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal CancerRecruitingNCT06934018Not applicable
- Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal CancerRecruitingNCT06928584Phase 2
- Exosome-based Recurrence Score for Post-Treatment Ovarian CancerNot yet recruitingNCT06925126
- Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)Not yet recruitingNCT06919848Phase 2
- Tamoxifen for Advanced Solid Pseudopapillary Tumor of the PancreasRecruitingNCT06914674Phase 2
- TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd ECRecruitingNCT06914297Phase 2
- Neoadjuvant SNF Precision Therapy Phase IIIRecruitingNCT06913777Phase 3
- Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast CancerRecruitingNCT06911528Not applicable
- A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal MetastasesRecruitingNCT06903325
- An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter PyloriRecruitingNCT06896370
- A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.RecruitingNCT06889610Phase 2
- MRD-Guided Surveillance in Locally Advanced Mid-Low Rectal Cancer (SURVEILLANCE-III)Not yet recruitingNCT06879899
- MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)Not yet recruitingNCT06879886
- MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)Not yet recruitingNCT06879873
- HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)RecruitingNCT06860490Phase 2
- Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)RecruitingNCT06860477Phase 2
- A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerRecruitingNCT06856200Not applicable
- Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal CancerRecruitingNCT06856187Phase 2
- Predicting Gastric Neoplasia in Patients with High-risk Endoscopic FeaturesNot yet recruitingNCT06853509
- IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)RecruitingNCT06849986Phase 2
- HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast CancerNot yet recruitingNCT06849492Phase 2
- Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal CancerRecruitingNCT06841159Phase 2
- MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal CancerRecruitingNCT06840665Phase 2
- Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06814067Phase 2
- HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of RecurrenceRecruitingNCT06812039Phase 2
- Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast CancerNot yet recruitingNCT06798506
- Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast CancerNot yet recruitingNCT06797622Phase 2
- Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer PatientsNot yet recruitingNCT06795503Phase 3
- BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADCRecruitingNCT06793332Phase 2
- Capecitabine in Low Risk Triple Negative Breast CancerRecruitingNCT06787339Phase 2
- Precision Palliative Care for Patients With Advanced Esophageal CancerRecruitingNCT06787313
- The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric CancerRecruitingNCT06786169
- QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBCRecruitingNCT06786026Phase 2